scholarly journals Alfuzosin Hydrochloride

2020 ◽  
Author(s):  
Keyword(s):  
Alfuzosin Hydrochloride

Development and Evaluation of Compression Coating Gastro-Floating Tablet of Alfuzosin Hydrochloride for Zero-Order Controlled Release

2018 ◽  
Vol 19 (7) ◽  
pp. 3277-3286 ◽  
Author(s):  
Ling Gong ◽  
Yanyan Sun ◽  
Miao Yu ◽  
Ying Gao ◽  
Meijuan Zou ◽  
...  
Keyword(s):  
Controlled Release ◽  
Zero Order ◽  
Floating Tablet ◽  
Alfuzosin Hydrochloride ◽  
Compression Coating

Alfuzosin hydrochloride

1986 ◽  
Vol 11 (10) ◽  
pp. 821 ◽  
Author(s):  
F. Borg ◽  
J.L. Cazor ◽  
M. Dimsdale
Keyword(s):  
Alfuzosin Hydrochloride

scholarly journals Development of ethosomes with taguchi robust design-based studies for transdermal delivery of alfuzosin hydrochloride

2012 ◽  
Vol 1 (11) ◽  
pp. 370-375 ◽  
Author(s):  
D Prasanthi ◽  
P K Lakshmi
Keyword(s):  
Robust Design ◽  
Transdermal Delivery ◽  
Design Method ◽  
Entrapment Efficiency ◽  
Pharmaceutical Journal ◽  
Dependent Variables ◽  
Alfuzosin Hydrochloride ◽  
Robust Design Method ◽  
Taguchi Robust Design ◽  
Drug Solution

In the present investigation efficiency of ethosomes as novel lipid carriers for transdermal delivery of Alfuzosin Hydrochloride (AH) has been evaluated. Taguchi robust design method was used for optimization of ethosomal formulations. Phospholipid type, concentration of phospholipid and concentration of ethanol was selected as independent variables and their effect on the dependent variables (entrapment efficiency and flux) was studied. Ethosomal formulation (EA8) with soya phosphatidylcholine (3%) and ethanol 20% were optimized. Vesicles were spherical, unilamellar with smooth surface. The optimized formulation exhibited vesicle size (6.85 ± 1.35µm), zeta potential (-8.14 ± 0.62mv), entrapment efficiency (91.86 ± 3.25%), flux (27.42 ± 0.04µg/cm2/hr), lag time (0.26±0.20hr) and skin deposition (298.01 ± 15.4µg/g). Transdermal flux was enhanced by 6.92 times over drug solution. Vesicle skin interaction studies showed fatty change in the dermis. The formulations were stable at 4°C for 120 days. Results suggested ethosomes as efficient carriers for AH transdermal delivery.DOI: http://dx.doi.org/10.3329/icpj.v1i11.12063 International Current Pharmaceutical Journal 2012, 1(11): 370-375

Release study of alfuzosin hydrochloride loaded to novel hydrogel P(HEMA-co-AA)

2008 ◽  
Vol 108 (1) ◽  
pp. 380-386 ◽  
Author(s):  
R. Mohapatra ◽  
D. Ray ◽  
A. K. Swain ◽  
T. K. Pal ◽  
P. K. Sahoo
Keyword(s):  
Release Study ◽  
Alfuzosin Hydrochloride
Sign in / Sign up

Export Citation Format

Share Document